SGLT2 inhibitors may offer benefit beyond diabetes

Overview of attention for article published in Nature Reviews Nephrology, December 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 108 X users

facebook: 3 Facebook pages

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 53 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 public wall posts from 3 users.

Bioquimica y biología molecular para estudiantes de medicina, 05 Jan 2021

Sodium–glucose co-transporter 2 inhibitors offer impressive cardiac and kidney outcome benefits to people with type 2 diabetes…

Nature Reviews, 04 Jan 2021

Nature Reviews Nephrology: Sodium–glucose co-transporter 2 inhibitors offer impressive cardiac and kidney outcome benefits to…

Nephro_OK, 03 Jan 2021

YEAR IN REVIEW: SGLT2 INHIBITORS IN…